Previous close | 28.16 |
Open | 27.98 |
Bid | 28.24 x 2200 |
Ask | 28.25 x 36900 |
Day's range | 28.27 - 28.37 |
52-week range | 25.20 - 40.37 |
Volume | |
Avg. volume | 41,859,126 |
Market cap | 160.25B |
Beta (5Y monthly) | 0.57 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.05 |
Earnings date | 30 Jul 2024 - 05 Aug 2024 |
Forward dividend & yield | 1.68 (5.97%) |
Ex-dividend date | 09 May 2024 |
1y target est | 29.16 |
Pfizer ( NYSE:PFE ) First Quarter 2024 Results Key Financial Results Revenue: US$14.9b (down 19% from 1Q 2023). Net...
Andrew Baum, the prominent Wall Street drug company analyst will be the pharma firm’s chief strategy and innovation officer.
Zacks.com users have recently been watching Pfizer (PFE) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.